Nefertiti Greene has become president of Mars Petcare’s new section Science & Diagnostics. She has begun his work on July 18, aiming to push the company into pet diagnostics and science and to help Waltham Petcare Science Institute.
The new division is based on the company’s pet biobank established in June 2022. It will operate in pet care across various areas like data science, dog and cat microbiomes, health and disease biomarkers and pet nutrition.
“Nefertiti will play an integral role in the continued growth of our diagnostics business and accelerate the impact of our science,” said Loic Moutault, president of Mars Petcare Global. “We’re very proud of our diagnostics business, which has a central role in the broader Mars Petcare ecosystem as an important way we deliver on our Purpose. And we recognize that shifting from curative to preventative veterinary care depends on being able to accurately predict and diagnose disease in pets.”
Greene has already worked for reputable companies such as head of enterprise strategy and chief of staff at Johnson & Johnson, US president and global president for Ethicon, Inc., president of Janssen Therapeutics. She started her more than 30 years of experience in general management, commercial operations, clinical research at Regeneron.
Next to her work career, Greene could call herself executive advisor for for the Enterprise Veterans Leadership Council, a member of the North American Diversity and Equity and Inclusion board. She is current member of the Executive Leadership Council and has already been honoured as P&L Leader of the Year by the National Association of Female Executives (NAFE).
“I am excited to join the Mars Petcare leadership team and look forward to using my experience in the healthcare industry to help build on the successes in diagnostics and science at Mars Petcare,” Greene said. “As a pet owner I’m looking forward to helping further the reach and impact of diagnostics and science for pets around the world.”